Tendering of Biosimilars | Insights from the Biosimilars Global Congress, 2022 Europe

Nov 08, 2022

The Biosimilars market in Europe, as well as globally, will continue to grow significantly over the coming years. Tendering & Contracting is the main procurement mechanism for Biosimilars.
A solid understanding of the tender biosimilar market combined with the application of optimal tendering practices are critical for long-term success.

Nico Bacharidis, Business advisor of Cube RM, participated at the 14th Biosimilars Global Congress, an event that covers a diverse range of topics on Biosimilars, presenting an overview of the Biosimilar tender market and all the key success factors of Tendering in this specific sector.

You can download the full deck by filling your details in the form below.

    SHOW DOWNLOAD LINK

    Keep Reading

    Private VS Public Tenders | Cube RM Tender Management

    ARTICLES

    TENDER MARKET INTELLIGENCE

    Public Tenders VS Private Tenders: Strategic Considerations for Life Sciences Companies
    Trends in Global Tendering | Cube RM Tender Management

    EVENTS

    TENDER MARKET INTELLIGENCE

    Trends in Global Tendering 2024 & how to shape them: A recap of World EPA Conference
    New tender sources | Cube RM Tender Management

    COMPANY & PRODUCT UPDATES

    TENDER MARKET INTELLIGENCE

    Expanding Tender Data and Coverage Globally – Integrating Tender Sources from Brazil, Thailand, and LMICs in Africa
    ALL NEWS